Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
Identifieur interne : 000307 ( Pmc/Curation ); précédent : 000306; suivant : 000308Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
Auteurs : B A Faucheux ; N. Nillesse ; P. Damier ; G. Spik ; A. Mouatt-Prigent ; A. Pierce ; B. Leveugle ; N. Kubis ; J J Hauw ; Y. AgidSource :
- Proceedings of the National Academy of Sciences of the United States of America [ 0027-8424 ] ; 1995.
Abstract
The degeneration of nigral dopaminergic neurons in Parkinson disease is believed to be associated with oxidative stress. Since iron levels are increased in the substantia nigra of parkinsonian patients and this metal catalyzes the formation of free radicals, it may be involved in the mechanisms of nerve cell death. The cause of nigral iron increase is not understood. Iron acquisition by neurons may occur from iron-transferrin complexes with a direct interaction with specific membrane receptors, but recent results have shown a low density of transferrin receptors in the substantia nigra. To investigate whether neuronal death in Parkinson disease may be associated with changes in a pathway supplementary to that of transferrin, lactoferrin (lactotransferrin) receptor expression was studied in the mesencephalon. In this report we present evidence from immunohistochemical staining of postmortem human brain tissue that lactoferrin receptors are localized on neurons (perikarya, dendrites, axons), cerebral microvasculature, and, in some cases, glial cells. In parkinsonian patients, lactoferrin receptor immunoreactivity on neurons and microvessels was increased and more pronounced in those regions of the mesencephalon where the loss of dopaminergic neurons is severe. Moreover, in the substantia nigra, the intensity of immunoreactivity on neurons and microvessels was higher for patients with higher nigral dopaminergic loss. These data suggest that lactoferrin receptors on vulnerable neurons may increase intraneuronal iron levels and contribute to the degeneration of nigral dopaminergic neurons in Parkinson disease.
Url:
PubMed: 7568181
PubMed Central: 40850
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000309
Links to Exploration step
PMC:40850Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.</title>
<author><name sortKey="Faucheux, B A" sort="Faucheux, B A" uniqKey="Faucheux B" first="B A" last="Faucheux">B A Faucheux</name>
</author>
<author><name sortKey="Nillesse, N" sort="Nillesse, N" uniqKey="Nillesse N" first="N" last="Nillesse">N. Nillesse</name>
</author>
<author><name sortKey="Damier, P" sort="Damier, P" uniqKey="Damier P" first="P" last="Damier">P. Damier</name>
</author>
<author><name sortKey="Spik, G" sort="Spik, G" uniqKey="Spik G" first="G" last="Spik">G. Spik</name>
</author>
<author><name sortKey="Mouatt Prigent, A" sort="Mouatt Prigent, A" uniqKey="Mouatt Prigent A" first="A" last="Mouatt-Prigent">A. Mouatt-Prigent</name>
</author>
<author><name sortKey="Pierce, A" sort="Pierce, A" uniqKey="Pierce A" first="A" last="Pierce">A. Pierce</name>
</author>
<author><name sortKey="Leveugle, B" sort="Leveugle, B" uniqKey="Leveugle B" first="B" last="Leveugle">B. Leveugle</name>
</author>
<author><name sortKey="Kubis, N" sort="Kubis, N" uniqKey="Kubis N" first="N" last="Kubis">N. Kubis</name>
</author>
<author><name sortKey="Hauw, J J" sort="Hauw, J J" uniqKey="Hauw J" first="J J" last="Hauw">J J Hauw</name>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y" last="Agid">Y. Agid</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">7568181</idno>
<idno type="pmc">40850</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC40850</idno>
<idno type="RBID">PMC:40850</idno>
<date when="1995">1995</date>
<idno type="wicri:Area/Pmc/Corpus">000309</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000309</idno>
<idno type="wicri:Area/Pmc/Curation">000307</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000307</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.</title>
<author><name sortKey="Faucheux, B A" sort="Faucheux, B A" uniqKey="Faucheux B" first="B A" last="Faucheux">B A Faucheux</name>
</author>
<author><name sortKey="Nillesse, N" sort="Nillesse, N" uniqKey="Nillesse N" first="N" last="Nillesse">N. Nillesse</name>
</author>
<author><name sortKey="Damier, P" sort="Damier, P" uniqKey="Damier P" first="P" last="Damier">P. Damier</name>
</author>
<author><name sortKey="Spik, G" sort="Spik, G" uniqKey="Spik G" first="G" last="Spik">G. Spik</name>
</author>
<author><name sortKey="Mouatt Prigent, A" sort="Mouatt Prigent, A" uniqKey="Mouatt Prigent A" first="A" last="Mouatt-Prigent">A. Mouatt-Prigent</name>
</author>
<author><name sortKey="Pierce, A" sort="Pierce, A" uniqKey="Pierce A" first="A" last="Pierce">A. Pierce</name>
</author>
<author><name sortKey="Leveugle, B" sort="Leveugle, B" uniqKey="Leveugle B" first="B" last="Leveugle">B. Leveugle</name>
</author>
<author><name sortKey="Kubis, N" sort="Kubis, N" uniqKey="Kubis N" first="N" last="Kubis">N. Kubis</name>
</author>
<author><name sortKey="Hauw, J J" sort="Hauw, J J" uniqKey="Hauw J" first="J J" last="Hauw">J J Hauw</name>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y" last="Agid">Y. Agid</name>
</author>
</analytic>
<series><title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
<idno type="ISSN">0027-8424</idno>
<idno type="eISSN">1091-6490</idno>
<imprint><date when="1995">1995</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>The degeneration of nigral dopaminergic neurons in Parkinson disease is believed to be associated with oxidative stress. Since iron levels are increased in the substantia nigra of parkinsonian patients and this metal catalyzes the formation of free radicals, it may be involved in the mechanisms of nerve cell death. The cause of nigral iron increase is not understood. Iron acquisition by neurons may occur from iron-transferrin complexes with a direct interaction with specific membrane receptors, but recent results have shown a low density of transferrin receptors in the substantia nigra. To investigate whether neuronal death in Parkinson disease may be associated with changes in a pathway supplementary to that of transferrin, lactoferrin (lactotransferrin) receptor expression was studied in the mesencephalon. In this report we present evidence from immunohistochemical staining of postmortem human brain tissue that lactoferrin receptors are localized on neurons (perikarya, dendrites, axons), cerebral microvasculature, and, in some cases, glial cells. In parkinsonian patients, lactoferrin receptor immunoreactivity on neurons and microvessels was increased and more pronounced in those regions of the mesencephalon where the loss of dopaminergic neurons is severe. Moreover, in the substantia nigra, the intensity of immunoreactivity on neurons and microvessels was higher for patients with higher nigral dopaminergic loss. These data suggest that lactoferrin receptors on vulnerable neurons may increase intraneuronal iron levels and contribute to the degeneration of nigral dopaminergic neurons in Parkinson disease.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><label>Fig. 1</label>
<graphic xlink:href="pnas01499-0185-a" xlink:role="9604"></graphic>
</fig>
<fig id="F2"><label>Fig. 2</label>
<graphic xlink:href="pnas01499-0186-a" xlink:role="9605"></graphic>
</fig>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">7568181</article-id>
<article-id pub-id-type="pmc">40850</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Faucheux</surname>
<given-names>B A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Nillesse</surname>
<given-names>N</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Damier</surname>
<given-names>P</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Spik</surname>
<given-names>G</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Mouatt-Prigent</surname>
<given-names>A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Pierce</surname>
<given-names>A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Leveugle</surname>
<given-names>B</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Kubis</surname>
<given-names>N</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Hauw</surname>
<given-names>J J</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Agid</surname>
<given-names>Y</given-names>
</name>
</contrib>
<etal></etal>
</contrib-group>
<aff>Institut National de la Santé et de la Recherche Médicale, Unité 289, Hôpital de la Salpêtrière, Paris, France.</aff>
<pub-date pub-type="ppub"><day>10</day>
<month>10</month>
<year>1995</year>
</pub-date>
<volume>92</volume>
<issue>21</issue>
<fpage>9603</fpage>
<lpage>9607</lpage>
<abstract><p>The degeneration of nigral dopaminergic neurons in Parkinson disease is believed to be associated with oxidative stress. Since iron levels are increased in the substantia nigra of parkinsonian patients and this metal catalyzes the formation of free radicals, it may be involved in the mechanisms of nerve cell death. The cause of nigral iron increase is not understood. Iron acquisition by neurons may occur from iron-transferrin complexes with a direct interaction with specific membrane receptors, but recent results have shown a low density of transferrin receptors in the substantia nigra. To investigate whether neuronal death in Parkinson disease may be associated with changes in a pathway supplementary to that of transferrin, lactoferrin (lactotransferrin) receptor expression was studied in the mesencephalon. In this report we present evidence from immunohistochemical staining of postmortem human brain tissue that lactoferrin receptors are localized on neurons (perikarya, dendrites, axons), cerebral microvasculature, and, in some cases, glial cells. In parkinsonian patients, lactoferrin receptor immunoreactivity on neurons and microvessels was increased and more pronounced in those regions of the mesencephalon where the loss of dopaminergic neurons is severe. Moreover, in the substantia nigra, the intensity of immunoreactivity on neurons and microvessels was higher for patients with higher nigral dopaminergic loss. These data suggest that lactoferrin receptors on vulnerable neurons may increase intraneuronal iron levels and contribute to the degeneration of nigral dopaminergic neurons in Parkinson disease.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><label>Fig. 1</label>
<graphic xlink:href="pnas01499-0185-a" xlink:role="9604"></graphic>
</fig>
<fig id="F2"><label>Fig. 2</label>
<graphic xlink:href="pnas01499-0186-a" xlink:role="9605"></graphic>
</fig>
</sec>
</abstract>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000307 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000307 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:40850 |texte= Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:7568181" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
This area was generated with Dilib version V0.6.29. |